Literature DB >> 19273072

IGF-IR in neuroprotection and brain tumors.

Elisa Gualco1, Jin Ying Wang, Luis Del Valle, Katarzyna Urbanska, Francesca Peruzzi, Kamel Khalili, Shohreh Amini, Krzysztof Reiss.   

Abstract

The IGF-IR is a multifunctional tyrosine kinase receptor involved in several biological processes including cell proliferation, differentiation, DNA repair, and cell survival. In the brain IGF-I plays a critical role during embryonic and early postnatal development. In the mature brain, IGF-I binding sites have been found in different regions of the brain, and multiple reports confirmed a strong neuroprotective action of the IGF-IR against different pro-apoptotic insults. When the IGF-IR signaling system is insufficiently deployed, either by low level of expression in elderly individuals, or by the inhibition associated with inflammatory cytokines, neuronal function and survival could be compromised. The examples of such CNS pathologies include HIV associated dementia, diabetic neuropathies, and Alzheimer's disease. On the other hand, elevated expression activity of the IGF-IR may support uncontrolled cell proliferation and protection from apoptosis. Probably the best example of the IGF-IR involvement in brain tumors is medulloblastomas in which functional cooperation between viral oncoprotein, JC virus large T-antigen, and IGF-IR has been recently established. Therefore, better understanding of the beneficial and potentially harmful aspects of the IGF-IR can be critical for the development of new clinical regimens against neurodegenerative disorders and brain tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273072      PMCID: PMC2679154          DOI: 10.2741/3249

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  272 in total

1.  Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

Authors:  A A Davies; J Y Masson; M J McIlwraith; A Z Stasiak; A Stasiak; A R Venkitaraman; S C West
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

Review 2.  Oncogenic potential of human neurotropic virus: laboratory and clinical observations.

Authors:  K Khalili; S Croul; L Del Valle; B Krynska; J Gordon
Journal:  Isr Med Assoc J       Date:  2001-03       Impact factor: 0.892

3.  RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.

Authors:  Ulrich Hermanto; Cong S Zong; Weiqun Li; Lu-Hai Wang
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

Authors:  J Zha; H Harada; E Yang; J Jockel; S J Korsmeyer
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

5.  Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice.

Authors:  G Camarero; C Avendano; C Fernandez-Moreno; A Villar; J Contreras; F de Pablo; J G Pichel; I Varela-Nieto
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 6.  The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases.

Authors:  Y Huang; N Erdmann; H Peng; Y Zhao; Jialin Zheng
Journal:  Cell Mol Immunol       Date:  2005-04       Impact factor: 11.530

7.  JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors.

Authors:  Danielle Shollar; Luis Del Valle; Kamel Khalili; Jessica Otte; Jennifer Gordon
Journal:  Oncogene       Date:  2004-07-15       Impact factor: 9.867

8.  Insulin-like growth factor-1-mediated AKT activation postpones the onset of ultraviolet B-induced apoptosis, providing more time for cyclobutane thymine dimer removal in primary human keratinocytes.

Authors:  David Decraene; Patrizia Agostinis; Roger Bouillon; Hugo Degreef; Marjan Garmyn
Journal:  J Biol Chem       Date:  2002-06-17       Impact factor: 5.157

9.  N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma.

Authors:  Samuel R Browd; Anna M Kenney; Oren N Gottfried; Joon Won Yoon; David Walterhouse; Carolyn A Pedone; Daniel W Fults
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

Review 10.  Role of insulin-like growth factor I signaling in neurodegenerative diseases.

Authors:  José Luis Trejo; Eva Carro; Eva Garcia-Galloway; Ignacio Torres-Aleman
Journal:  J Mol Med (Berl)       Date:  2003-11-28       Impact factor: 4.599

View more
  9 in total

1.  Acute Ethanol Increases IGF-I-Induced Phosphorylation of ERKs by Enhancing Recruitment of p52-Shc to the Grb2/Shc Complex.

Authors:  Matthew Dean; Adam Lassak; Anna Wilk; Adriana Zapata; Luis Marrero; Patricia Molina; Krzysztof Reiss
Journal:  J Cell Physiol       Date:  2016-12-19       Impact factor: 6.384

2.  Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-α-mediated neuronal damage: implications for human immunodeficiency virus encephalitis.

Authors:  Anna Wilk; Katarzyna Urbanska; Shuo Yang; Jin Ying Wang; Shohreh Amini; Luis Del Valle; Francesca Peruzzi; Leonard Meggs; Krzysztof Reiss
Journal:  J Neurosci Res       Date:  2010-12-08       Impact factor: 4.164

Review 3.  Nuclear IRS-1 and cancer.

Authors:  Krzysztof Reiss; Luis Del Valle; Adam Lassak; Joanna Trojanek
Journal:  J Cell Physiol       Date:  2012-08       Impact factor: 6.384

4.  Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma.

Authors:  Clifford J Cookman; Scott M Belcher
Journal:  Endocrinology       Date:  2015-04-17       Impact factor: 4.736

5.  Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas.

Authors:  Pei-Fang Wu; Wen-Chang Huang; James Chih-Hsin Yang; Yen-Shen Lu; Jin-Yuan Shih; Shang-Gin Wu; Ching-Hung Lin; Ann-Lii Cheng
Journal:  J Neurooncol       Date:  2013-07-02       Impact factor: 4.130

6.  Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

Authors:  Emmanuel de Billy; Marsha Pellegrino; Domenico Orlando; Giulia Pericoli; Roberta Ferretti; Pietro Businaro; Maria Antonietta Ajmone-Cat; Sabrina Rossi; Lucia Lisa Petrilli; Nicola Maestro; Francesca Diomedi-Camassei; Marco Pezzullo; Cristiano De Stefanis; Paola Bencivenga; Alessia Palma; Rossella Rota; Francesca Del Bufalo; Luca Massimi; Gerrit Weber; Chris Jones; Andrea Carai; Simona Caruso; Biagio De Angelis; Ignazio Caruana; Concetta Quintarelli; Angela Mastronuzzi; Franco Locatelli; Maria Vinci
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

7.  Negative regulation of Grb10 Interacting GYF Protein 2 on insulin-like growth factor-1 receptor signaling pathway caused diabetic mice cognitive impairment.

Authors:  Jing Xie; Qianping Wei; Huacong Deng; Gang Li; Lingli Ma; Hui Zeng
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

8.  Gene expression by simian virus 40 large T antigen-induced medulloblastomas in mice.

Authors:  Xiaoluan Wei; Jie Feng; Yinghe Hu
Journal:  Neural Regen Res       Date:  2012-04-25       Impact factor: 5.135

9.  Less hippocampal neuronal death in young gerbils following transient global cerebral ischemia is associated with long‑term maintenance of insulin‑like growth factor 1 and its receptors in the hippocampal CA1 region.

Authors:  Bing Chun Yan; Jie Wang; Jianwen Cao; Moo-Ho Won
Journal:  Mol Med Rep       Date:  2017-12-11       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.